Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

candidemia - Clinical Profile, Treatments & Trials | Kisho | Kisho

Rare Disease

candidemia

MONDO:0044070

Also known as:Candidemias

Find Clinical TrialsTrials

Overview

A form of invasive candidiasis where species of candida are present in the blood.

Treatments9 FDA approved

Clinical Trials7 registered · 1 recruiting

Diagnosis

Biomarker and diagnostic research for candidemia has been reported in the published literature.

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

7 FDA-approved treatments are available for candidemia, including REZAFUNGIN (REZZAYO, approved 2023), ANIDULAFUNGIN (ERAXIS, approved 2006), and VORICONAZOLE (VORICONAZOLE, approved 2017).

Approved Therapies

Brand Name	Generic Name	Mechanism	Approved	Market Status

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

7 clinical trials registered, 1 recruiting. Interventions under study include drug therapy. Pipeline includes 1 PHASE4, 3 PHASE3, 2 PHASE2. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT05421858](https://clinicaltrials.gov/study/NCT05421858)

Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 8:08 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→What are the benefits and potential side effects of REZZAYO for managing candidemia?
→Are any of the 7 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Disease patterns and progression	101	44%
Research summaries	56	24%
Testing and diagnosis research	20	9%
Laboratory research	20	9%
Clinical study results	17	7%
Patient case studies	11	5%
New treatment approaches	3	1%
Other research	2	1%

Kisho

candidemia

Overview

Diagnosis

Treatment

Approved Therapies

Research Landscape

Medical References

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials

Recent Publications

Latest News & Developments

Successful conservative treatment of MRSA-associated infective endocarditis with concurrent candidemia in a hemodialysis patient.

candidemia

Overview

Diagnosis

Treatment

Approved Therapies

Research Landscape

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials

Recent Publications

Latest News & Developments

Successful conservative treatment of MRSA-associated infective endocarditis with concurrent candidemia in a hemodialysis patient.